By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


National Cancer Institute (NCI) 

NCI Public Inquiries Office
Building, 31, Room 10A03
31 Center Drive, MSC 2

Bethesda  Maryland  20892-2580  U.S.A.
Phone: 301-435-3848 Fax:



Maxygen, Inc. 

Genzyme General 

PanVera LLC 

Panacos Pharmaceuticals Inc.  Panacos has a CRADA with leading scientists at the National Cancer Institute to study the mechanism of HIV maturation inhibitors and to discover new antiviral drugs.

Company News
NCI Selects ATCC To Distribute Cutting-Edge Cancer Models To Support The Human Cancer Models Initiative 10/20/2016 9:51:26 AM
Eli Lilly (LLY) Partners With The NCI To Accelerate Cancer Research Through New Program Under Cancer Moonshot Initiative 10/17/2016 10:17:25 AM
NCI Awards Major Contract To Southern Research 10/6/2016 7:09:01 AM
OncoTAb Awarded NCI Contract To Develop A Targeted Therapy For Triple Negative Breast Cancer 10/5/2016 9:09:10 AM
Kinetic River Corp. Awarded Contract From NCI For Potomac Modular Flow Cytometer 10/5/2016 8:28:09 AM
Riptide Bioscience Announces Cooperative Research And Development Agreement With The NCI 10/4/2016 8:08:44 AM
NCI Japan Purchases ViewRay MRIdian System 9/21/2016 8:20:47 AM
Abilita Bio Awarded NCI Phase-I SBIR Grant To Develop Therapeutic Antibodies Targeting Metastatic Breast Cancer 9/20/2016 10:38:22 AM
BioMarker Strategies Awarded Phase I NCI Contract To Develop Novel Predictive Test For Response To Immunotherapies For Patients With Non-Small Cell Lung Cancer 9/19/2016 11:11:25 AM
Lumicell Awarded Direct Phase II SBIR Grant From The NCI To Conduct Multi-Center Pivotal Study 8/9/2016 12:44:00 PM